Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Perrigo Secures API Divestiture for $110M | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Perrigo Secures API Divestiture for $110M

The completed sale, based in Israel, was to SK Capital

By: Betsy Louda

, Contract Pharma

Perrigo Company has completed the divestiture of its active pharmaceutical ingredient (API) business based in Israel to SK Capital for $110 million. The company is also one of the world’s largest manufacturers of over-the-counter (OTC) healthcare products and suppliers of infant formulas.

 

“Actions taken as part of this review process have enabled us to simplify, focus and execute on our core businesses. We continue to look at capital deployment opportunities that drive value for shareholders and further our mission of providing quality, affordable healthcare products to consumers around the globe,” said Perrigo’s chief executive officer, John T. Hendrickson.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics